Post-COVID condition (PCC, "Long COVID") — defined by WHO as symptoms persisting or developing beyond 4 weeks of COVID-19 onset — affects an estimated 10–30% of survivors, representing 10–15 million Americans with significant ongoing disability. After initial uncertainty about whether PCC was a distinct clinical entity or psychosomatic manifestation, a substantial evidence base has accumulated: documented pathophysiological mechanisms (viral persistence, immune dysregulation, microbiome disruption, mitochondrial dysfunction, endothelial damage), validated biomarker signatures, and beginning evidence for targeted interventions. Healthcare facilities managing PCC patients require appropriate clinical supplies from our patient care, respiratory, and rehabilitation catalogs.
Recognized Clinical Phenotypes
PCC is not a single disease but a cluster of overlapping syndromes requiring phenotype-specific management. The most recognized phenotypes: (1) Post-exertional malaise (PEM)/ME-CFS-like — worsening of symptoms with physical or cognitive exertion, disproportionate to the effort; cardinal feature distinguishing PCC from other post-viral syndromes; any exercise program must use pacing, not progressive overload; (2) Dysautonomia/POTS — orthostatic tachycardia, dizziness, pre-syncope; responds to salt loading, compression garments, beta-blockers, and volume expansion; (3) Cognitive dysfunction ("brain fog") — processing speed and working memory impairment; potentially driven by neuroinflammation and cerebral hypoperfusion; (4) Cardiopulmonary — exertional dyspnea with normal cardiopulmonary testing in most (functional breathlessness), or documented pulmonary fibrosis in severe cases; (5) Chest pain — musculoskeletal (costochondritis common post-COVID), cardiac (myocarditis in rare cases), or esophageal dysmotility.
Evidence-Based Management
Pacing for PEM/ME-CFS: heart rate variability-guided activity pacing — keeping HR below the anaerobic threshold to avoid post-exertional crashes — is the foundational intervention for ME-CFS-like PCC. Graded exercise therapy (GET) is explicitly contraindicated for PCC with PEM — this distinction from traditional post-viral rehabilitation is critical. POTS management: compression garments (knee-high 30–40 mmHg) from our orthopedic catalog provide significant symptom relief; fluid and salt loading (2–3L fluid, 3–5g sodium daily) expands plasma volume; elevating the head of the bed 15–20° reduces orthostatic challenge during sleep. Respiratory rehabilitation: breathing retraining (diaphragmatic breathing, pursed lip breathing for breathlessness) is effective for functional breathlessness — hyperventilation syndrome is common in PCC. COVID antivirals (Paxlovid, administered during acute infection) significantly reduce PCC development probability — a 2023 VA study found paxlovid treatment reduced Long COVID likelihood by 26%.
